Substance Name: Agalsidase alfa [USAN:INN:BAN]
RN: 104138-64-9
Note
- Fenetically engineered, glycosylated human alpha-galactosidase isoenzyme A used in treatment of Fabry disease.
Molecular Formula
- Unspecified
Classification Codes
- Therapeutic Enzymes
- Treatment of Fabry Disease
* denotes mobile formatted website
Links to Resources
NLM Resources (File Locators)
Other Resources (Internet Locators)
Names and Synonyms
Name of Substance
- Agalsidase alfa
- Agalsidase alfa [USAN:INN:BAN]
- Agalsidase beta [INN]
Synonyms
- Agalsidase alfa
- Agalsidase beta
- alpha-Galactosidase (human clone lambdaAG(sup 18) isoenzyme A subunit protein moiety reduced), glycoform beta
- alpha-Galactosidase (human-clone lambdaAG(sup 18) isoenzyme A subunit protein moiety reduced). Molecular weight is approximately 45,351 daltons
- Alpha-galactosidase A
- EC 3.2.1.22
- Fabrazyme
- Galactosidase, alpha- (CHO cell line CTH-158 plasmid PGB86)
- Galactosidase, alpha- (human clone lambdaAG18 isoenzyme A subunit protein moiety reduced)
- Galactosidase, alpha- (human Clone PGB73)
- Galactosidase, alpha- (human isoenzyme A reduced)
- Replagal
- UNII-2HLC17MX9G
- UNII-RZD65TSM9U
Systematic Name
- Galactosidase, alpha-(human clone lambdaAG18 isoenzyme A subunit protein moiety reduced)
Registry Numbers
CAS Registry Number
- 104138-64-9
FDA UNIIs
- 2HLC17MX9G
- RZD65TSM9U
System Generated Number
- 0104138649